lifestyle.forkstofeet.com

Author: Aclarion, Inc.

Aclarion Announces Agreement with Weill Cornell Medicine

April 8, 2026
Aclarion Highlights Growing Adoption of Nociscan at The London Clinic with New Physician Video

April 7, 2026
Aclarion, Inc. Adopts Limited Duration Stockholder Rights Plan

March 19, 2026
Aclarion Publishes CEO Shareholder Letter Highlighting Strategic Progress and 2026 Catalysts

March 19, 2026
Aclarion to Participate in the 38th Annual ROTH Conference, Highlighting Key 2026 Catalysts and Strong Balance Sheet

March 17, 2026
Aclarion CEO Brent Ness to Attend LSI USA 2026

March 12, 2026
Aclarion Publishes 2026 Shareholder Letter from the Chairman

February 11, 2026
Aclarion Adds High-Volume Practice, Source Healthcare, to Support Nociscan Growth and Real-World Evidence Generation

February 3, 2026